Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-22-017505)

Filing Details

Accession Number:: 0001493152-22-017505
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-22 16:55:55
Reporting Period:: 2022-06-22

Accepted Time:: 2022-06-22 16:55:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1460702	Qualigen Therapeutics Inc.	QLGN	Pharmaceutical Preparations (2834)	263474527

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1812504	S. Michael Poirier	C/O Qualigen Therapeutics, Inc., 2042 Corte Del Nogal Carlsbad CA 92011	Chairman And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-06-22	30,000	$0.57	199,202	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	11,005	Indirect	By IRA